KIF3C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.538600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.757200E-01
Normal-vs-Stage2
5.441400E-01
Normal-vs-Stage3
2.682200E-01
Normal-vs-Stage4
5.856800E-01
Stage1-vs-Stage2
7.805400E-01
Stage1-vs-Stage3
6.285600E-01
Stage1-vs-Stage4
6.372000E-01
Stage2-vs-Stage3
4.058400E-01
Stage2-vs-Stage4
6.881400E-01
Stage3-vs-Stage4
2.489800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.571000E-01
Normal-vs-AfricanAmerican
8.139800E-01
Normal-vs-Asian
2.152200E-01
Caucasian-vs-AfricanAmerican
3.448000E-01
Caucasian-vs-Asian
3.730200E-01
AfricanAmerican-vs-Asian
1.346410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.654600E-01
Normal-vs-Female
2.735000E-01
Male-vs-Female
6.289600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.002000E-01
Normal-vs-Age(41-60Yrs)
4.266600E-01
Normal-vs-Age(61-80Yrs)
2.336000E-01
Normal-vs-Age(81-100Yrs)
2.154400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.163800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.398000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.246200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.241800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.057380E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.845800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.328800E-01
Normal-vs-Daily Drinker
4.459600E-01
Normal-vs-Weekly Drinker
5.818000E-01
Normal-vs-Occasional Drinker
7.437600E-01
Normal-vs-Social Drinker
5.403600E-01
Non Drinker-vs-Daily Drinker
8.923200E-01
Non Drinker-vs-Weekly Drinker
1.914980E-01
Non Drinker-vs-Occasional Drinker
5.151600E-02
Non Drinker-vs-Social Drinker
1.827980E-01
Daily Drinker-vs-Weekly Drinker
2.818200E-01
Daily Drinker-vs-Occasional Drinker
6.936100E-02
Daily Drinker-vs-Social Drinker
1.832180E-01
Weekly Drinker-vs-Occasional Drinker
3.487400E-01
Weekly Drinker-vs-Social Drinker
6.902000E-01
Occasional Drinker-vs-Social Drinker
6.155200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.254800E-01
Normal-vs-Grade 2
1.615570E-01
Normal-vs-Grade 3
2.209400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.294400E-01
Grade 1-vs-Grade 3
7.298400E-01
Grade 1-vs-Grade 4
3.254800E-01
Grade 2-vs-Grade 3
8.306000E-01
Grade 2-vs-Grade 4
1.615570E-01
Grade 3-vs-Grade 4
2.209400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.098400E-01
Normal-vs-NonDiabetic
2.543400E-01
Diabetic-vs-NonDiabetic
9.219000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.357800E-01
Normal-vs-NoPancreatitis
2.802200E-01
Pancreatitis-vs-NoPancreatitis
9.526800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.079800E-01
Normal-vs-N1
5.666400E-01
N0-vs-N1
6.140000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.615000E-01
Normal-vs-TP53-NonMutant
3.524000E-01
TP53-Mutant-vs-TP53-NonMutant
7.883200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
